Find clinical trials for Breast Cancer in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Taipei City, TWN:
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Taipei, Taiwan and 71 other locations
Breast cancer (BC), especially premenopausal, is emerging rapidly in East Asia in recent 20 years. Half of the breast cancer...
Phase 2
Taipei, Taiwan
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Taipei, Taiwan and 319 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Taipei, Taiwan and 144 other locations
DESTINY-Breast 08 will investigate the safety, tolerability, PK and preliminary anti-tumour activity of T-DXd in combination with other ther ...
Phase 1
Taipei, Taiwan and 36 other locations
Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer pa ...
Taipei, Taiwan
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Taipei, Taiwan and 166 other locations
-negative (HR+/HER2-) advanced breast cancer....
Phase 1, Phase 2
Taipei, Taiwan and 14 other locations
Olaparib, a PARP inhibitor, is proven as an effective therapy for germline BRCA1/2-mutated breast cancer; however, the therapeutic ...
Phase 2
Taipei, Please Select, Taiwan and 2 other locations
versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....
Phase 3
Taipei, Taiwan and 163 other locations
Clinical trials
Research sites
Resources
Legal